Stay updated on Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, indicating a newer document revision. This reflects a metadata update to the page rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-05-14T22:36:19.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.3, replacing v3.5.2, indicating a minor page revision. This is a metadata-level update rather than a substantive change to the page content.
    Difference
    0.1%
    Check dated 2026-04-30T15:39:03.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:12:43.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:49:40.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 to reflect the latest build.
    Difference
    0.1%
    Check dated 2026-03-11T16:55:18.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 and the previous funding/status notice (Revision: v3.4.1) has been removed; this appears to be a routine maintenance update with no impact on study data or user interaction. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T03:08:29.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.